The California Emerging Therapies Research Partnership Act.

{"id": "ocd-bill/fc58740c-d093-4db4-8c98-e0f70d7e5e14", "session": "20252026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:ca/government", "name": "California", "classification": "state"}, "from_organization": {"id": "ocd-organization/98623fa0-f9c3-47ae-80bb-51465349ed71", "name": "Senate", "classification": "upper"}, "identifier": "SB 1224", "title": "The California Emerging Therapies Research Partnership Act.", "classification": ["bill", "appropriation"], "subject": ["TheCaliforniaEmergingTherapiesResearchPartnershipAct"], "extras": {"tags": ["fiscal committee"], "impact_clause": "An act to add Division 10.3 (commencing with Section 11730) to the Health and Safety Code, relating to controlled substances, and making an appropriation therefor."}, "created_at": "2026-02-20T08:55:33.768011+00:00", "updated_at": "2026-07-14T06:46:24.017171+00:00", "openstates_url": "https://openstates.org/ca/bills/20252026/SB1224/", "first_action_date": "2026-02-19", "latest_action_date": "2026-07-01", "latest_action_description": "From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (June 30). Re-referred to Com. on APPR.", "latest_passage_date": "2026-05-28"}